Ossiam’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.91M | Buy |
23,843
+3,210
| +16% | +$265K | 0.03% | 170 |
|
|
2025
Q4 | $1.76M | Sell |
20,633
-8,731
| -30% | -$717K | 0.04% | 163 |
|
|
2025
Q3 | $2.28M | Sell |
29,364
-26,805
| -48% | -$2.09M | 0.03% | 319 |
|
|
2025
Q2 | $4.39M | Buy |
56,169
+18,492
| +49% | +$1.38M | 0.05% | 183 |
|
|
2025
Q1 | $2.73M | Buy |
37,677
+4,153
| +12% | +$297K | 0.04% | 190 |
|
|
2024
Q4 | $2.48M | Sell |
33,524
-549
| -2% | -$38.4K | 0.04% | 212 |
|
|
2024
Q3 | $2.25M | Sell |
34,073
-4,030
| -11% | -$293K | 0.04% | 200 |
|
|
2024
Q2 | $3.52M | Buy |
38,103
+5,015
| +15% | +$444K | 0.07% | 148 |
|
|
2024
Q1 | $3.16M | Buy |
33,088
+4,033
| +14% | +$339K | 0.06% | 185 |
|
|
2023
Q4 | $2.22M | Buy |
29,055
+1,955
| +7% | +$136K | 0.04% | 210 |
|
|
2023
Q3 | $1.88M | Sell |
27,100
-91,539
| -77% | -$7.36M | 0.03% | 220 |
|
|
2023
Q2 | $11.2M | Buy |
118,639
+86,214
| +266% | +$7.49M | 0.2% | 99 |
|
|
2023
Q1 | $2.68M | Buy |
32,425
+6,950
| +27% | +$546K | 0.06% | 175 |
|
|
2022
Q4 | $1.9M | Sell |
25,475
-1,374
| -5% | -$106K | 0.05% | 202 |
|
|
2022
Q3 | $2.22M | Buy |
26,849
+9,597
| +56% | +$923K | 0.06% | 178 |
|
|
2022
Q2 | $1.64M | Sell |
17,252
-128,505
| -88% | -$13.3M | 0.05% | 177 |
|
|
2022
Q1 | $17.2M | Sell |
145,757
-12,060
| -8% | -$1.35M | 0.45% | 52 |
|
|
2021
Q4 | $20.4M | Sell |
157,817
-8,156
| -5% | -$951K | 0.54% | 49 |
|
|
2021
Q3 | $18.8M | Buy |
165,973
+5,902
| +4% | +$674K | 0.53% | 42 |
|
|
2021
Q2 | $18M | Sell |
160,071
-17,978
| -10% | -$1.69M | 0.49% | 48 |
|
|
2021
Q1 | $14.9M | Buy |
178,049
+32,365
| +22% | +$2.74M | 0.46% | 52 |
|
|
2020
Q4 | $13.3M | Buy |
145,684
+75,532
| +108% | +$6.27M | 0.46% | 52 |
|
|
2020
Q3 | $5.6M | Sell |
70,152
-1,654
| -2% | -$129K | 0.23% | 73 |
|
|
2020
Q2 | $4.96M | Sell |
71,806
-45,554
| -39% | -$3.24M | 0.32% | 65 |
|
|
2020
Q1 | $7.38M | Buy |
117,360
+116,148
| +9,583% | +$8.38M | 0.5% | 44 |
|
|
2019
Q4 | $94K | Sell |
1,212
-2,289
| -65% | -$179K | 0.01% | 397 |
|
|
2019
Q3 | $257K | Buy |
3,501
+2,703
| +339% | +$190K | 0.02% | 299 |
|
|
2019
Q2 | $49K | Sell |
798
-7,062
| -90% | -$427K | ﹤0.01% | 424 |
|
|
2019
Q1 | $501K | Buy |
7,860
+4,698
| +149% | +$268K | 0.04% | 173 |
|
|
2018
Q4 | $161K | Buy |
+3,162
| New | +$160K | 0.02% | 203 |
|
Other funds holding EW
VCM
VPM
Ossiam's EW Position: Q1 2026 in Review
Ossiam increased its Edwards Lifesciences (EW) stake by 16% in Q1 2026, buying an estimated $265K and bringing the position to 23,843 shares worth $1.91M. The position accounts for 0.03% of the portfolio, ranked #170.
Ossiam first reported a position in EW in Q4 2018 and has held it in 30 quarters since. The position peaked at $20.4M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Ossiam held 23,843 shares of Edwards Lifesciences worth $1.91M as of Q1 2026.
- Ossiam bought 3,210 Edwards Lifesciences shares in Q1 2026, an estimated $265K.
- Edwards Lifesciences made up 0.03% of Ossiam's portfolio in Q1 2026, its #170 holding.
- Ossiam first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 30 quarters since.
- Ossiam's Edwards Lifesciences position peaked at $20.4M in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.